Ratifi Español Sign in
Ratifi

Federal bills from Congress.gov. State bills from Open States.

A 4852Session 222

Revises certain requirements for prescription of Schedule II controlled dangerous substances via telemedicine and telehealth without in-person examination or review.*

Read the full bill

Progress

  1. Introduced
  2. In committee
  3. Passed House
  4. Passed legislature
  5. Sent to governor
  6. Became law

Votes

  1. HousePassed

    3RDG FINAL PASSAGE

    76 yes2 no2 other

    How each member voted
    PartyYesNoOther
    Democrats2300
    Republicans1011

    Yes (76)

    No (2)

    Didn’t vote (2)

  2. SenatePassed

    3RDG FINAL PASSAGE

    38 yes2 no

    How each member voted
    PartyYesNoOther
    Democrats1700
    Republicans820

    Yes (38)

    No (2)

  3. HousePassed

    Reported out of Assembly committee as a substitute

    7 yes0 no

    How each member voted
    PartyYesNoOther
    Democrats300
    Republicans100

    Yes (7)

Legislative history

  1. House

    Approved P.L.2026, c.40.

  2. Senate

    Passed Senate (Passed Both Houses) (38-2)

  3. House

    Substituted for S4194/4210 (SCS)

  4. Senate

    Received in the Senate without Reference, 2nd Reading

  5. House

    Passed by the Assembly (76-2-1)

  6. House

    Reported from Assembly Comm. as a Substitute, 2nd Reading

  7. House

    Transferred to Assembly State and Local Government Committee

  8. House

    Introduced, Referred to Assembly Health Committee